![Andres Briseno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 939 543 $ al 31/07/2026
Andres Ruiz Briseno is Chief Accounting Officer at IDEAYA Biosciences, Inc. since 2025.
Previously, Mr. Briseno was Associate Director-Financial Planning & Analysis at Pharmacyclics LLC from 2013 to 2016.
Mr. Briseno completed an undergraduate degree at San Jose State University in 2009.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC. 0,03 % | 07/07/2026 | 26.466 ( 0,03 % ) | 939 543 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/08/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
